Arthur Williams
Infectious Disease · Harrisburg, PANPI 1104924539
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,460 of the $95,611 with a category attached, or 69.5%. Gilead accounts for 97.8% of it on its own, with 14 other manufacturers making up the rest. Among infectious disease clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $423.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$94K
- Viiv Healthcare Company$701
- Novo Nordisk$294
- Lilly USA, LLC$248
- Johnson & Johnson$220
- AbbVie$177
- plus $461 from 9 others
What the payments were for
- Consulting fees$5,4506%
- Speaking & faculty fees$66,46070%
- Travel & lodging$19,54420%
- Food & beverage$4,0334%
- Education$1240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 148 | $93,510 |
| Viiv Healthcare Company | 26 | $701 |
| Novo Nordisk | 12 | $294 |
| Lilly USA, LLC | 10 | $248 |
| Johnson & Johnson(2 entities) | 6 | $220 |
| AbbVie | 4 | $177 |
| Exact Sciences | 4 | $106 |
| Abbott | 6 | $101 |
| Janssen Products, LP | 1 | $96 |
| GSK | 4 | $74 |
| Phadia US Inc. | 1 | $23 |
| Merck | 1 | $17 |
| Pfizer | 1 | $15 |
| Amgen | 1 | $15 |
| Theratechnologies Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$95,611 in reported general payments places this provider in the 95th percentile of 457 infectious disease providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 20 | $87,209 |
| EliquisApixaban | 37 | $32,371 |
| JanuviaSitagliptin Phosphate | 34 | $26,711 |
| JardianceEmpagliflozin | 31 | $24,471 |
| TrulicityDulaglutide | 12 | $14,898 |
| XareltoRivaroxaban | 15 | $12,657 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $6,794 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $4,061 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $2,969 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 112 | $2,866 |
| Atorvastatin Calcium | 217 | $2,112 |
| Lisinopril | 138 | $975 |
| Omeprazole | 104 | $874 |
| Nifedipine ErNifedipine | 49 | $837 |
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 12 | $835 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $93,510 | $87,20920 claims |
| PfizerEliquis | $15 | $32,37137 claims |
| MerckJanuvia | $17 | $26,71134 claims |
| Lilly USA, LLCTrulicity | $248 | $14,89812 claims |
| Johnson & JohnsonXarelto | $220 | $12,65715 claims |
| GSKTrelegy Ellipta | $74 | $6,79411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 457 infectious disease providers in Pennsylvania.
Other infectious disease in Harrisburg
- David HornPhiladelphia$2.1M
- Judith WolfPhiladelphia$1.2M
- Karam MounzerPhiladelphia$712K
- William ShortPhiladelphia$520K
- David WuWest Chester$483K
- William PaceSouthampton$472K
- Amesh AdaljaPittsburgh$415K
- Brett GilbertWynnewood$352K
- Timothy BabinchakPhoenixville$311K
- Tuesdae Stainbrookdu Bois$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.